85 related articles for article (PubMed ID: 21280316)
1. [Evaluation on clinical value of serum CA-125 level in hepatitis cirrhosis].
Xu J; Liu J; Guo JX; Ma HB; Zhao J; Liu AX; Xu WN; Li BA; Mao YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):334-6. PubMed ID: 21280316
[TBL] [Abstract][Full Text] [Related]
2. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
Jabłkowski M; Białkowska J; Koktysz R; Bartkowiak J; Stankiewicz W; Dworniak D
Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
[TBL] [Abstract][Full Text] [Related]
3. Cancer Antigen-125 as a marker of ascites in patients with liver cirrhosis.
Qureshi MO; Dar FS; Khokhar N
J Coll Physicians Surg Pak; 2014 Apr; 24(4):232-5. PubMed ID: 24709233
[TBL] [Abstract][Full Text] [Related]
4. Serum CA-125 measurements > 65 U/mL. Clinical value.
Eltabbakh GH; Belinson JL; Kennedy AW; Gupta M; Webster K; Blumenson LE
J Reprod Med; 1997 Oct; 42(10):617-24. PubMed ID: 9350014
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum CA 125 in patients with chronic liver diseases].
Kim YS; Kim DY; Ryu KH; Song JH; Kim MS; Jung HS; Park JY; Jung HK; Yoo K; Moon IH; Baek JY
Korean J Gastroenterol; 2003 Nov; 42(5):409-14. PubMed ID: 14646578
[TBL] [Abstract][Full Text] [Related]
6. Cancer antigen 125 in patients with chronic liver disease.
Devarbhavi H; Kaese D; Williams AW; Rakela J; Klee GG; Kamath PS
Mayo Clin Proc; 2002 Jun; 77(6):538-41. PubMed ID: 12059123
[TBL] [Abstract][Full Text] [Related]
7. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
8. Serum tumor markers in chronic liver disease.
Kadayifci A; Simsek H; Savas MC; Toppare M
Neoplasma; 1996; 43(1):17-21. PubMed ID: 8843954
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis.
Xiao WB; Liu YL
J Gastroenterol Hepatol; 2003 Nov; 18(11):1315-6. PubMed ID: 14535990
[TBL] [Abstract][Full Text] [Related]
12. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
[TBL] [Abstract][Full Text] [Related]
13. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
14. Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis.
Chowdhury MA; Xiubin Z; Wei H; Chenghao G
Clin Lab; 2014; 60(4):653-8. PubMed ID: 24779300
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal reaction and serum glycoprotein concentration in chronic hepatitis and liver cirrhosis.
Fehér J; Jakab L; Józsa L; Szilvási I; Papp G
Acta Morphol Acad Sci Hung; 1975; 23(4):319-26. PubMed ID: 1234831
[TBL] [Abstract][Full Text] [Related]
16. Cancer antigen 125 levels in serum can predict the recurrence of ascites in patients with cirrhosis of the liver.
Aguilar-Reina J; Rey-Romero C; Ortega-Viñas M; Hernandez-Pascual A; Sayago-Mota M
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():163-5. PubMed ID: 2083930
[TBL] [Abstract][Full Text] [Related]
17. Chylous ascites with marked elevation of CA-125 in cirrhosis.
Kumar KS; Lee WM
Am J Gastroenterol; 2000 Nov; 95(11):3313-4. PubMed ID: 11095368
[No Abstract] [Full Text] [Related]
18. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
19. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
[TBL] [Abstract][Full Text] [Related]
20. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
